<p align=center>Email sended at 24-07-2017 14:03:49</p>
              	<li>to:</li>
                <li>headers:From: comitati-etici-toscana@no-reply.it<comitati-etici-toscana@no-reply.it>
BCC: g.contino@cineca.it
CC: silvia.benemei@unifi.it
Reply-To: <>
Return-Path: comitati-etici-toscana@no-reply.it<comitati-etici-toscana@no-reply.it>
Message-ID: <1500905029-comitati-etici-toscana@no-reply.it>
MIME-Version: 1.0
Content-Type: multipart/mixed;
 boundary="7694db879273fdae7df961cb5c54e838"

</li>
                <li>oggetto:Segreteria CEAV Centro - notifica di parere sospensivo</li>
                <li>testo:La segreteria CEAV Centro ha inviato parere sospensivo per lo studio 'Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Crohn's Disease'.<br> E' possibile visualizzarne i dettagli tramite il seguente link:<br> <a href="https://ricercaclinica-toscana.cineca.it/uxmr/index.php?&exams=visite_exam.xml&ID_STUD=11153">Vai allo studio</a>&nbsp;</li>
                <hr><p align=center>Email sended at 24-07-2017 16:12:11</p>
              	<li>to:</li>
                <li>headers:From: comitati-etici-toscana@no-reply.it<comitati-etici-toscana@no-reply.it>
BCC: g.contino@cineca.it
CC: silvia.benemei@unifi.it
Reply-To: <>
Return-Path: comitati-etici-toscana@no-reply.it<comitati-etici-toscana@no-reply.it>
Message-ID: <1500912731-comitati-etici-toscana@no-reply.it>
MIME-Version: 1.0
Content-Type: multipart/mixed;
 boundary="3a3ce9c95a1a8f0297921e6a461234b3"

</li>
                <li>oggetto:Segreteria CEAV Centro - notifica di parere sospensivo</li>
                <li>testo:La segreteria CEAV Centro ha inviato parere sospensivo per lo studio 'Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis.'.<br> E' possibile visualizzarne i dettagli tramite il seguente link:<br> <a href="https://ricercaclinica-toscana.cineca.it/uxmr/index.php?&exams=visite_exam.xml&ID_STUD=10857">Vai allo studio</a>&nbsp;</li>
                <hr>